Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion description "[A daily subcutaneous infusion of 18-base, fully phosporothioated antisense oligonucleotide was administered for 2 weeks to nine patients who had BCL-2-positive relapsed non-Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion evidence source_evidence_literature NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion SIO_000772 9113013 NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion wasDerivedFrom befree-2016 NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion wasGeneratedBy ECO_0000203 NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- befree-2016 importedOn "2016-02-19" NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.